Clopidogrel hydrogen sulfate(CAS: 120202-66-6)

CAS Number
Related Products
10,11-Dihydro-5H-dibenzo[b,f]azepine
CAS Number: 494-19-9
1,2,3-thiadiazol-5-amine
CAS Number: 4100-41-8
5H-Dibenzo[b,f]azepine-5-carboxamide
CAS Number: 298-46-4
Oxcarbazepine
CAS Number: 28721-07-5
Lamotrigine
CAS Number: 84057-84-1
5H-Dibenzo[b,f]azepine
CAS Number: 256-96-2
Other Suppliers for Clopidogrel hydrogen sulfate
Basic Information
Molecular Formula
C16H18ClNO6S2
Molecular Weight
419.91 g/mol
Physical Properties
Melting Point
178-184°C
Boiling Point
447.3°C at 760 mmHg
Chemical Identifiers
SMILES
COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O
InChIKey
FDEODCTUSIWGLK-RSAXXLAASA-N
Database References
MDL Number
MFCD00876395
FAQ
Clopidogrel hydrogen sulfate (CAS: 120202-66-6) is a pharmaceutical compound used as an antiplatelet agent. Its chemical formula is C16H16N2O2S·H2SO4, and it is a white to off-white powder with good solubility in water. It functions as a prodrug, converting to active metabolites that inhibit platelet aggregation, making it vital in cardiovascular disease management.
Clopidogrel hydrogen sulfate (CAS: 120202-66-6) is primarily used in pharmaceuticals to treat and prevent thrombotic events like heart attacks and strokes. It is also employed in research for drug development and as an intermediate in industrial chemical syntheses. Its antiplatelet properties make it a key component in cardiovascular therapy.
Clopidogrel hydrogen sulfate (CAS: 120202-66-6) is generally safe when used as directed, but it may cause side effects such as bleeding risks. Handling precautions include wearing gloves and avoiding eye contact. It meets safety standards for pharmaceutical use, with regulatory approval from the FDA and other agencies for prescribed medical applications.
Clopidogrel hydrogen sulfate (CAS: 120202-66-6) should be stored in a cool, dry place below 25°C, away from light. Maintain low humidity and use airtight, light-resistant containers. Keep it in a secure location to prevent contamination or misuse, ensuring stability and efficacy of the compound.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Zhjuven Pharmaceutical

![10,11-Dihydro-5H-dibenzo[b,f]azepine](https://static.chemtradehub.com/structs/494/494-19-9-86d6.webp)

![5H-Dibenzo[b,f]azepine-5-carboxamide](https://static.chemtradehub.com/structs/298/298-46-4-91b9.webp)

![5-{4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione](https://static.chemtradehub.com/structs/111/111025-46-8-b48b.webp)


![(3S)-2-{N-[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]-L-alanyl}-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid](https://static.chemtradehub.com/structs/854/85441-61-8-08c4.webp)
![5H-Dibenzo[b,f]azepine](https://static.chemtradehub.com/structs/256/256-96-2-7261.webp)

